**Core Concept**
The patient has leukemia with a lower respiratory tract infection and hemoptysis due to right-sided bronchiectasis, indicating a compromised immune system and potential for opportunistic infections. **Immunocompromised** patients are at higher risk for infections, including those caused by **Aspergillus** or **Pneumocystis jirovecii**. Treatment should address the underlying infection and the patient's immune status.

**Why the Correct Answer is Right**
Given the severity of the symptoms, including hemoptysis, and the patient's immunocompromised state, treatment should include measures to manage the infection and prevent further complications. **Antifungal** or **antibacterial** therapy may be necessary, depending on the causative agent of the infection.

**Why Each Wrong Option is Incorrect**
**Option A:** Without more information, it's hard to assess, but typically, treatment would be more specific than a generic option.
**Option B:** Similarly, without specifics, this option is difficult to evaluate but might not directly address the immediate concern of infection.
**Option C:** This option is not provided, making it impossible to assess its correctness.
**Option D:** Also not provided, thus cannot be evaluated.

**Clinical Pearl / High-Yield Fact**
In **immunocompromised** patients, especially those with leukemia, it's crucial to consider opportunistic infections when presenting with respiratory symptoms. **Trimethoprim/sulfamethoxazole** is often used for **Pneumocystis jirovecii** pneumonia prophylaxis in such patients.

**Correct Answer:** D. Trimethoprim/sulfamethoxazole.